6.37
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MYGN Giù?
Forum
Previsione
Frazionamento azionario
Myriad Genetics Inc Azioni (MYGN) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
8.78%
213.10
|
195.90 | 210.60 | 213.30 | 211.50 |
Cost Of Revenue |
0.65%
61.30
|
61.70 | 59.70 | 63.50 | 64.40 |
Gross Profit |
13.11%
151.80
|
134.20 | 150.90 | 149.80 | 147.10 |
|
194.73%
481.00
|
163.20 | 189.90 | 169.80 | 183.60 |
Benefits Costs and Expenses |
141.32%
543.70
|
225.30 | 249.70 | 234.50 | 248.70 |
Costs And Expenses |
141.32%
543.70
|
225.30 | 249.60 | 233.30 | 248.00 |
Depreciation and Amortization |
2.08%
14.10
|
14.40 | 14.80 | 15.60 | 15.10 |
Operating Income/Loss |
1,035%
-329.20
|
-29.00 | -39.00 | -20.00 | -36.50 |
Nonoperating Income/Loss |
250.00%
-1.40
|
-0.40 | -0.10 | -1.20 | -0.70 |
Income/Loss From Continuing Operations Before Tax |
1,024%
-330.60
|
-29.40 | -39.10 | -21.20 | -37.20 |
Income Tax Expense/Benefit |
99.66%
-0.10
|
-29.30 | 3.40 | 0.90 | -0.50 |
Income/Loss From Continuing Operations After Tax |
330.40K%
-330.50
|
-0.10 | -42.50 | -22.10 | -36.70 |
|
330.40K%
-330.50
|
-0.10 | -42.50 | -22.10 | -36.70 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
1.20%
92.50
|
91.40 | 0.10 | 90.90 | 90.60 |
Diluted Average Shares |
1.20%
92.50
|
91.40 | 0.10 | 90.90 | 90.60 |
Basic Earnings Per Share |
-3.57
|
- | -0.47 | -0.24 | -0.41 |
Diluted Earnings Per Share |
-3.57
|
- | -0.47 | -0.24 | -0.41 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):